HK1067958A1 - Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells - Google Patents

Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells

Info

Publication number
HK1067958A1
HK1067958A1 HK05100178A HK05100178A HK1067958A1 HK 1067958 A1 HK1067958 A1 HK 1067958A1 HK 05100178 A HK05100178 A HK 05100178A HK 05100178 A HK05100178 A HK 05100178A HK 1067958 A1 HK1067958 A1 HK 1067958A1
Authority
HK
Hong Kong
Prior art keywords
monoclonal antibodies
directed against
antibodies directed
selfcytotoxic
cells
Prior art date
Application number
HK05100178A
Other languages
English (en)
Inventor
Allen D. Allen
Original Assignee
Allen Allen D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen Allen D filed Critical Allen Allen D
Publication of HK1067958A1 publication Critical patent/HK1067958A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK05100178A 1993-03-19 2005-01-08 Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells HK1067958A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3340593A 1993-03-19 1993-03-19
US16575193A 1993-12-13 1993-12-13
CA002425086A CA2425086A1 (en) 1993-03-19 2003-04-10 Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies

Publications (1)

Publication Number Publication Date
HK1067958A1 true HK1067958A1 (en) 2005-04-22

Family

ID=34084057

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100178A HK1067958A1 (en) 1993-03-19 2005-01-08 Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells

Country Status (11)

Country Link
US (1) US5424066A (xx)
EP (2) EP0690725B1 (xx)
AT (2) ATE408418T1 (xx)
AU (1) AU684074B2 (xx)
CA (2) CA2156495C (xx)
DE (2) DE69435142D1 (xx)
DK (1) DK1438970T3 (xx)
ES (2) ES2314341T3 (xx)
HK (1) HK1067958A1 (xx)
PT (2) PT1438970E (xx)
WO (1) WO1994021295A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5651970A (en) * 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
US6534057B2 (en) 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
WO1995028176A1 (en) * 1994-04-15 1995-10-26 Allen Allen D Method of treating hiv infection using antibodies against cytotoxic t-cells and thymic humoral factor
AU720126B2 (en) * 1995-04-14 2000-05-25 Kabushiki Kaisha Tokyo Kagaku Kenkyusho Phosphor with afterglow characteristic
AU6256796A (en) * 1995-06-06 1996-12-24 D. Allen Allen Method for treating molluscum contagiosum resulting from hiv infection
WO1996040215A1 (en) * 1995-06-07 1996-12-19 Connective Therapeutics, Inc. Treating immune deficiency diseases using t cell receptor peptides
CA2252790A1 (en) * 1997-02-28 1998-09-03 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (sidr)
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
US6919077B2 (en) * 2002-09-27 2005-07-19 Aids Research, Llc LFA-1 alpha subunit antibodies and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002869A (en) * 1987-11-02 1991-03-26 Dana-Farber Cancer Institute Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes

Also Published As

Publication number Publication date
WO1994021295A1 (en) 1994-09-29
EP1438970A2 (en) 2004-07-21
DK1438970T3 (da) 2008-12-15
US5424066A (en) 1995-06-13
EP0690725A1 (en) 1996-01-10
DE69433789T2 (de) 2005-06-23
EP0690725B1 (en) 2004-05-19
PT1438970E (pt) 2008-12-26
AU684074B2 (en) 1997-12-04
PT690725E (pt) 2004-10-29
ES2314341T3 (es) 2009-03-16
DE69433789D1 (de) 2004-06-24
ES2219647T3 (es) 2004-12-01
ATE267019T1 (de) 2004-06-15
ATE408418T1 (de) 2008-10-15
EP1438970A3 (en) 2004-12-08
CA2156495A1 (en) 1994-09-29
AU6522194A (en) 1994-10-11
CA2425086A1 (en) 2004-10-10
DE69435142D1 (de) 2008-10-30
EP1438970B1 (en) 2008-09-17
CA2156495C (en) 2008-11-18
EP0690725A4 (en) 1997-09-03

Similar Documents

Publication Publication Date Title
HK1067958A1 (en) Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells
IL135221A0 (en) Natural humanized antibody and methods for the preparation thereof
EP0539970A3 (en) Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
EP1266965A3 (en) Recombinant antibodies for human therapy
AU3215895A (en) Human-murine chimeric antibodies against respiratory syncytial virus
DE69319728D1 (de) Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
AU1520895A (en) Purified primate ctla-8 antigens and related reagents
EP0701696A4 (en) ANTIGENS OF THE BLUST STADIUM OF PLSAMODIUM VIVAX, ANTIBODIES AND DIAGNOSTIC TESTS
DK0840618T3 (da) Induktion af immunologisk tolerance ved anvendelse af uudtømmelige anti-CD4-antistoffer
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
AU658987B2 (en) Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
AU1715292A (en) Human immunodeficiency virus-related immune preparation
WO1994021295B1 (en) Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells
CA2160696A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU627540B2 (en) Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
MX9804880A (es) Anticuerpos que reconocen cadenas de azucar y remedios para enfermedades infeccionsas por vih.
GB2267148B (en) Footrot antigens,vaccines and diagnostic assays
TH14186EX (th) การใช้ในการรักษาโรคของแอนติบอดีซิเมอริคและแอนติบอดีที่ติดตามได้ด้วยกัมมันตรังสีต่อแอนติเจนที่มีการแบ่งแยกความแตกต่างอย่างจำกัดของลิมโฟไซท์ชนิด b ในมนุษย์ เพื่อการรักษาลิมโฟมาของเซล b
AU6769594A (en) Hepatitis c virus immunodiagnostic antigens and antibodies
EP0672120A4 (en) THE PRODUCTION OF HUMAN, MONOCLONAL ANTIBODIES THAT ARE ACTIVE AGAINST HEPATITIS B SURFACE ANTIQUE.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120321